Discussion on inflammatory⁃cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies based on theory of latent toxicity due to vital qi deficiency
|更新时间:2023-04-08
|
Discussion on inflammatory⁃cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies based on theory of latent toxicity due to vital qi deficiency
Shanghai Journal of Traditional Chinese MedicineVol. 57, Issue 4, Pages: 8-12(2023)
LU Xinyi,LUO Bin,QUE Zujun,et al.Discussion on inflammatory⁃cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies based on theory of latent toxicity due to vital qi deficiency[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(4):8-12.
LU Xinyi,LUO Bin,QUE Zujun,et al.Discussion on inflammatory⁃cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies based on theory of latent toxicity due to vital qi deficiency[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(4):8-12. DOI: 10.16305/j.1007-1334.2023.2301028.
Discussion on inflammatory⁃cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies based on theory of latent toxicity due to vital qi deficiency
We aim to discuss the inflammatory-cancer transformation of pulmonary nodules and traditional Chinese medicine prevention and treatment strategies by reviewing the mechanism of pulmonary nodule development. The key to the inflammation-cancer transformation of pulmonary nodules is latent toxicity due to vital qi deficiency. Therefore, the important way to prevent the development of lung cancer is to support vital qi and expel pathogens. One proven case is provided.
关键词
肺结节肺癌正虚伏毒炎-癌转化中医药防治
Keywords
pulmonary nodulelung cancerlatent toxicity due to vital qi deficiencyinflammation-cancer transformationtraditional Chinese medicine prevention and treatment
references
ZHENG R S, ZHANG S W , ZENG H M, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
FENG R M, ZONG Y N, CAO S M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun (Lond), 2019, 39(1): 22.
ALLEMANI C, MATSUDA T, DI CARLO V, et al. Global surveillance of trends in cancer survival 2000-14(CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
GRIVENNIKOV S I, GRETEN F R, KARIN M. Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6): 883-899.
HOU J, KARIN M, SUN B. Targeting cancer-promoting inflammation-have anti-inflammatory therapies come of age? [J]. Nat Rev Clin Oncol, 2021, 18(5): 261-279.